Prognosis of patients with primary melanoma stage I and II according to American Joint Committee on Cancer version 8 validated in two independent cohorts: implications for adjuvant treatment
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
June 16, 2022
|
| In: |
Journal of clinical oncology
Year: 2022, Volume: 40, Issue: 32, Pages: 3741-3749 |
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.22.00202 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/JCO.22.00202 Resolving-System: http://dx.doi.org/10.1200/JCO.22.00202 Verlag, lizenzpflichtig, Volltext: http://ascopubs.org/doi/pdf/10.1200/JCO.22.00202?role=tab |
| Author Notes: | Claus Garbe, Ulrike Keim, Teresa Amaral, Carola Berking, Thomas K. Eigentler, Lukas Flatz, Anja Gesierich, Ulrike Leiter, Rudolf Stadler, Cord Sunderkötter, Thomas Tüting, Jochen Utikal, Uwe Wollina, Lisa Zimmer, Christos C. Zouboulis, Paolo A. Ascierto, Alexander M. M. Eggermont, Jean-Jacques Grob, Axel Hauschild, Lidija Kandolf Sekulovic, Georgina V. Long, Jason J. Luke, Olivier Michielin, Ketty Peris, Dirk Schadendorf, John M. Kirkwood, and Paul C. Lorigan, on behalf of the Central Malignant Melanoma Registry (CMMR) |
| Physical Description: | Online Resource |
|---|---|
| ISSN: | 1527-7755 |
| DOI: | 10.1200/JCO.22.00202 |